Among the immune subsets, the percentage of tumor-infiltrated NKs (CD49b+), DCs (CD11c+), and T cells (CD3+) in the B16F10-IL9+BMDM group increased by 15-, 13-, and 5.5-fold, respectively. Here, ITGAX is linked to neoplasm.